Published in Virology on November 01, 1983
Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol (1996) 5.44
A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci U S A (1985) 2.74
Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus. J Virol (1985) 2.41
Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products. J Virol (1987) 2.30
The 89,000-Mr murine cytomegalovirus immediate-early protein activates gene transcription. J Virol (1986) 2.08
Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol (1988) 1.83
Host immune response to cytomegalovirus: products of transfected viral immediate-early genes are recognized by cloned cytolytic T lymphocytes. J Virol (1987) 1.47
Characterization of the murine cytomegalovirus early transcription unit e1 that is induced by immediate-early proteins. J Virol (1990) 1.45
Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. J Virol (1986) 1.11
Analysis of a region of the human cytomegalovirus (AD169) genome coding for a 25-kilodalton virion protein. J Virol (1989) 1.04
Animal cytomegaloviruses. Microbiol Rev (1990) 1.02
Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic mice. Am J Pathol (1999) 0.86
Guinea pig cytomegalovirus immediate-early transcription. J Virol (1990) 0.83
Transplacental murine cytomegalovirus infection in the brain of SCID mice. Virol J (2007) 0.82
Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A (2001) 13.30
Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites. Cell (1978) 7.46
Transcription in human fibroblasts permissively infected by human cytomegalovirus strain AD169. Virology (1983) 4.58
Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in DNA of uninfected vertebrates. Proc Natl Acad Sci U S A (1978) 4.47
Polyadenylic acid on poliovirus RNA. II. poly(A) on intracellular RNAs. J Virol (1975) 3.65
Myosin vb is associated with plasma membrane recycling systems. Mol Biol Cell (2001) 3.45
Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol (1995) 3.18
Detection of human cytomegalovirus in clinical specimens by DNA-DNA hybridization. J Infect Dis (1984) 3.10
BRCA2 mutations in primary breast and ovarian cancers. Nat Genet (1996) 2.91
Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene. J Virol (1988) 2.90
Requirement of 3'-terminal poly(adenylic acid) for the infectivity of poliovirus RNA. Proc Natl Acad Sci U S A (1974) 2.89
Human immunodeficiency virus infection of human-PBL-SCID mice. Science (1991) 2.77
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A (2000) 2.70
Class V myosins. Biochim Biophys Acta (2000) 2.62
Cleavage maps for human cytomegalovirus DNA strain AD169 for restriction endonucleases EcoRI, BglII, and HindIII. J Virol (1982) 2.59
Construction of a cloned library of the EcoRI fragments from the human cytomegalovirus genome (strain AD169). J Virol (1982) 2.52
Characteristics of cellular RNA related to the transforming gene of avian sarcoma viruses. Cell (1978) 2.50
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene (2008) 2.47
Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci U S A (1991) 2.27
A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res (2001) 2.22
Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol (1998) 2.18
Analysis of the major transcripts encoded by the long repeat of human cytomegalovirus strain AD169. J Virol (1985) 2.15
In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins. Mol Cell Biol (1993) 2.11
Uninfected avian cells contain RNA related to the transforming gene of avian sarcoma viruses. Cell (1978) 2.10
Identification of a new virulence locus in Agrobacterium tumefaciens that affects polysaccharide composition and plant cell attachment. J Bacteriol (1987) 2.08
Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith Strain). Virology (1983) 2.06
Identification of proteins in the postsynaptic density fraction by mass spectrometry. J Neurosci (2000) 1.98
Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J Virol (1994) 1.94
Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res (1992) 1.93
2.2-kilobase class of early transcripts encoded by cell-related sequences in human cytomegalovirus strain AD169. J Virol (1986) 1.91
Artificial neural networks improve the accuracy of cancer survival prediction. Cancer (1997) 1.91
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci U S A (2001) 1.89
Cultured melanocytes from dilute mutant mice exhibit dendritic morphology and altered melanosome distribution. Proc Natl Acad Sci U S A (1996) 1.88
Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci U S A (1992) 1.87
Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol (1988) 1.83
Enzymatic amplification of human cytomegalovirus sequences by polymerase chain reaction. J Clin Microbiol (1989) 1.81
Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol (2000) 1.81
Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem (1995) 1.78
Structure of the heterogeneous L-S junction region of human cytomegalovirus strain AD169 DNA. J Virol (1984) 1.73
Retroviral sequences located within an intron of the dilute gene alter dilute expression in a tissue-specific manner. EMBO J (1995) 1.66
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res (1995) 1.62
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst (1993) 1.60
p53 overexpression in advanced-stage endometrial adenocarcinoma. Am J Obstet Gynecol (1996) 1.59
Maintenance of p53 alterations throughout breast cancer progression. Cancer Res (1991) 1.58
Sequences in the human cytomegalovirus 2.7-kilobase RNA promoter which mediate its regulation as an early gene. J Virol (1989) 1.57
p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol (1998) 1.57
Absence of the tight junctional protein AF-6 disrupts epithelial cell-cell junctions and cell polarity during mouse development. Curr Biol (1999) 1.52
The human cytomegalovirus IE2 86-kilodalton protein interacts with an early gene promoter via site-specific DNA binding and protein-protein associations. J Virol (1995) 1.52
Polyadenylic acid on poliovirus RNA IV. Poly(U) in replicative intermediate and double-stranded RNA. Virology (1975) 1.51
Post-transcriptional control of avian oncornavirus transforming gene sequences in mammalian cells. Nature (1977) 1.48
Cloning and characterization of myr 6, an unconventional myosin of the dilute/myosin-V family. Proc Natl Acad Sci U S A (1996) 1.47
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ (1996) 1.45
Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit. J Virol (1989) 1.45
Four phosphoproteins with common amino termini are encoded by human cytomegalovirus AD169. J Virol (1988) 1.44
Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter. J Virol (1994) 1.44
Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation (1991) 1.43
CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J Virol (1996) 1.43
Terminal structure and heterogeneity in human cytomegalovirus strain AD169. J Virol (1986) 1.42
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ (1994) 1.42
Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J Virol (1998) 1.41
Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res (1998) 1.36
Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development. Development (1991) 1.35
Transcription analysis and sequence of the putative murine cytomegalovirus DNA polymerase gene. Virology (1991) 1.33
Cell cycle control of BRCA2. Cancer Res (1996) 1.32
M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene (1996) 1.31
Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery (1991) 1.31
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog (1996) 1.27
An AP-1 binding site is the predominant cis-acting regulatory element in the 1.2-kilobase early RNA promoter of human cytomegalovirus. J Virol (1992) 1.24
The human cytomegalovirus 2.7-kilobase RNA promoter contains a functional binding site for the adenovirus major late transcription factor. J Virol (1990) 1.24
Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. Int J Gynecol Cancer (2006) 1.23
DNA immunization confers protection against murine cytomegalovirus infection. J Virol (1996) 1.22
Regenerating adult chicken skeletal muscle and satellite cell cultures express embryonic patterns of myosin and tropomyosin isoforms. Dev Biol (1983) 1.21
Specific chromosome 1 breaks induced by human cytomegalovirus. Proc Natl Acad Sci U S A (2000) 1.21
The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol (1994) 1.16
Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65). J Virol (2000) 1.16
Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet Gynecol (1993) 1.16
Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res (1990) 1.15
Myosin-I nomenclature. J Cell Biol (2001) 1.14
Engineering of the myosin-ibeta nucleotide-binding pocket to create selective sensitivity to N(6)-modified ADP analogs. J Biol Chem (1999) 1.14
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. J Natl Cancer Inst (1992) 1.13
Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene (1992) 1.13
Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ (2000) 1.13
Dhh1 regulates the G1/S-checkpoint following DNA damage or BRCA1 expression in yeast. J Surg Res (2003) 1.12
p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry. J Histochem Cytochem (1992) 1.12
Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res (1992) 1.11
Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. J Virol (1986) 1.11
Polyadenylic acid on poliovirus RNA. III. In vitro addition of polyadenylic acid to poliovirus RNAs. J Virol (1975) 1.09
Subversion of cell cycle regulatory pathways. Curr Top Microbiol Immunol (2008) 1.09
Replication of the murine cytomegalovirus genome: structure and role of the termini in the generation and cleavage of concatenates. Virology (1988) 1.08
The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus. J Virol (1994) 1.08
Studies on the function of polyadenylic acid on poliovirus RNA. Cell (1975) 1.07
Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection. J Virol (1998) 1.05
Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type-1 production in monocyte-derived macrophages. Virology (1994) 1.05